China NMPA Product Recall - Ventilator

Philips (China) Investment Co., Ltd. initiated a voluntary Class II recall of its ventilators, as announced by the National Medical Products Administration (NMPA) on April 14, 2021. This action follows the discovery that certain motor components within the affected devices may contain substandard plastic materials. The presence of these inadequate plastics poses a risk of generating exhaust gases, which could lead to structural failures and sudden operational malfunctions of the ventilators during patient use. While the company has not yet received reports of adverse events directly linked to this specific issue, the recall is a proactive measure to ensure patient safety and product reliability. The recall specifically targets ventilators with Registration Certificate Nos. 20163545170 and 20192082053, with detailed product models, specifications, and batch information available in the accompanying "Medical Device Recall Event Report Form." This voluntary recall by Philips (China) operates under the oversight of the NMPA, reflecting the company's commitment to regulatory compliance and product quality in the medical device sector. The company is actively working to address the identified material defect and manage the recall process to mitigate potential risks to users.